Innovative Robotic System Tested for Throat Cancer Surgery at King's College London

A groundbreaking study led by King's College London, in collaboration with the University of Oxford and Guy's and St Thomas' NHS Foundation Trust, has demonstrated the potential of a new robotic surgical system for treating head and neck conditions, particularly throat cancer. This advancement marks a significant step forward in minimally invasive oncologic procedures.

The research focused on the Versius Surgical System, created by UK-based CMR Surgical, which was evaluated for its application in transoral robotic surgery (TORS). TORS is a technique that allows surgeons to remove tumors from the throat through the mouth, avoiding the need for more invasive open surgeries. Over an eight-month period, a team of experienced surgeons carried out 30 robotic procedures using the Versius system—15 for benign conditions and 15 for malignant tumors—completing all surgeries successfully without major complications or the necessity to switch to traditional open surgery.

This study represents the first clinical application of the Versius robotic system in human patients for transoral procedures. According to Jack Faulkner, Head and Neck Robotic Research Fellow at King's College London, this development expands the scope of robotic options available for head and neck cancer treatments, potentially making these procedures safer, more efficient, and more accessible.

The study employed the IDEAL framework, a structured approach for assessing surgical innovations. Initially, the system was tested on benign cases, followed by cancer surgeries, which helped refine surgical techniques and adapt the system to the complex anatomy of the oropharynx.

A notable feature tested was the four-arm robotic surgery capability, using three instruments plus a camera simultaneously—a setup that is not common with most current multi-port systems. While this approach offered improved surgical access and reduced workload on bedside assistants, it also posed challenges in confined spaces like the tongue base.

Surgeons identified some areas needing improvement, such as bulky instruments and lack of precision. The team emphasizes the need for TORS-specific tools, including a monopolar spatula, to optimize the system's performance. Further multi-center studies are recommended to evaluate its broader applicability and to refine instrumentation.

Dr. Asist Arora, Senior Lecturer at King's College London, underscored the significance of this work, highlighting that it set the stage for eventual regulatory approval and broader clinical application, benefiting many patients with throat cancer seeking minimally invasive options.

This pioneering research signifies a promising advancement in robotic head and neck surgery, potentially transforming treatment approaches and expanding access to less invasive cancer care in the future.